Medically reviewed by Drugs.com. Last updated on May 5, 2021.
Generic name: RISDIPLAM 0.75mg in 1mL
Dosage form: powder, for oral solution
Important Administration Instructions
It is recommended that a healthcare provider discuss with the patient or caregiver how to prepare the prescribed daily dose prior to administration of the first dose [see Instructions for Use].
Instruct patients or caregivers to prepare the dose using the reusable oral syringe provided.
EVRYSDI must be taken immediately after it is drawn up into the oral syringe. If EVRYSDI is not taken within 5 minutes, EVRYSDI should be discarded from the oral syringe, and a new dose should be prepared.
EVRYSDI is taken orally once daily after a meal at approximately the same time each day.
In infants who are breastfed, EVRYSDI should be administered after breastfeeding. EVRYSDI cannot be mixed with formula or milk.
Instruct patients to drink water after taking EVRYSDI to ensure the drug has been completely swallowed.
If the patient is unable to swallow and has a nasogastric or gastrostomy tube, EVRYSDI can be administered via the tube. The tube should be flushed with water after delivering EVRYSDI [see Instructions for Use].
EVRYSDI is administered orally once daily. The recommended dosage is determined by age and body weight (see Table 1).
|Age and Body Weight||Recommended Daily Dosage|
|2 months to less than 2 years of age||0.2 mg/kg|
|2 years of age and older weighing less than 20 kg||0.25 mg/kg|
|2 years of age and older weighing 20 kg or more||5 mg|
If a dose of EVRYSDI is missed, EVRYSDI should be administered as soon as possible if still within 6 hours of the missed dose, and the usual dosing schedule can be resumed on the next day. Otherwise, the missed dose should be skipped, and the next dose should be taken at the regularly scheduled time on the next day.
If a dose is not fully swallowed or vomiting occurs after taking a dose of EVRYSDI, another dose should not be administered to make up for the lost dose. The patient should wait until the next day to take the next dose at the regularly scheduled time.
Preparation of Oral Solution by Pharmacists
EVRYSDI powder must be constituted to the oral solution by a pharmacist prior to dispensing to the patient.
Preparation of the EVRYSDI Oral Solution 0.75 mg/mL
Caution should be exercised in the handling of EVRYSDI powder for oral solution. Avoid inhalation and direct contact with skin or mucous membranes with the dry powder and the constituted solution. If such contact occurs, wash thoroughly with soap and water; rinse eyes with water. Wear disposable gloves during the preparation and cleanup procedure.
- Gently tap the bottom of the closed glass bottle to loosen the powder.
- Remove the cap. Do not throw away the cap.
- Carefully pour 79 mL of Purified Water into the EVRYSDI bottle to yield the 0.75 mg/mL oral solution. Do not mix EVRYSDI with formula or milk.
- Insert the Press-In bottle adapter into the bottle opening by pushing it down against the bottle lip. Ensure it is completely pressed against the bottle lip.
- Re-cap the bottle tightly and shake well for 15 seconds. Wait for 10 minutes. You should have obtained a clear solution. If not, shake well again for another 15 seconds.
- Write the date of expiration of the constituted oral solution (calculated as 64 days after constitution) and the lot number on the bottle label. Peel off the part of the bottle label that has the expiration date of the powder.
- Put the bottle back in its original carton.
- Select the appropriate oral syringes (6 mL or 12 mL) based on the patient's dosage and remove the other oral syringes from the carton.
- Dispense with the "Instructions for Use" and FDA-approved patient labeling. Alert patients to read the important handling information described in the Instructions for Use.
Keep the constituted oral solution of EVRYSDI in the original amber bottle to protect from light. Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Discard any unused portion 64 days after constitution. Keep the bottle in an upright position with the cap tightly closed.
Frequently asked questions
- Evrysdi vs Spinraza: How do they compare?
- How does it work for SMA?
- How effective is it?
- Does it cure spinal muscular atrophy (SMA)?
- How is it administered?
More about Evrysdi (risdiplam)
- Side Effects
- During Pregnancy
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: miscellaneous uncategorized agents
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.